- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05399238
Thermography and Burning Mouth Syndrome (TDSBA)
Thermography as a Non-ionizing Quantitative Tool for Diagnosing of Burning Mouth Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
An objective of this study is to standardize temperature values derived from thermograms of the tongue in BMS
Subjects will make one visit to our clinic with burning mouth syndrome and control healthy . They will be asked to acclimate to room temperature for at least 20 minutes. Subjects are requested not to consume hot drinks or food for at least an hour before imaging and not to use any skin preparations. During the tests, infrared thermal images were taken immediately after subjects protruded their tongues forward and downward to the desired position
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Murcia, Spain, 30004
- Pia Lopez Jornet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Written informed consent signed he patients were diagnosed with BMS according to the criteria of the International Classification of Headache Disorders
Exclusion Criteria:
- Fibromyalgia
- Fever
- Reflux
- Cancer,
- Oral infection,
- Pregnant or breastfeeding women
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy subjects
The objective is to measure the temperature of the lingual dorsum
|
Subjects will make one visit to our clinic with burning mouth syndrome and control healthy .
They will be asked to acclimate to room temperature for at least 20 minutes.
Subjects are requested not to consume hot drinks or food for at least an hour before imaging and not to use any skin preparations.
|
Burning mouth syndrome
The objective is to measure the temperature of the lingual dorsum
|
Subjects will make one visit to our clinic with burning mouth syndrome and control healthy .
They will be asked to acclimate to room temperature for at least 20 minutes.
Subjects are requested not to consume hot drinks or food for at least an hour before imaging and not to use any skin preparations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of temperature tongue
Time Frame: Day 1am . experimental subject and each control subject will be seen once for the administration of the thermography imagery
|
Tongue temperature areas: tongue tip, middle, left lateral, right lateral,changes in colour pixels will be analysed to determine temperature changes since this is a measurement or diagnostic study using thermographic imagery, there is no health risk to the subjects.
|
Day 1am . experimental subject and each control subject will be seen once for the administration of the thermography imagery
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Lv C, Wang X, Chen J, Yang N, Fisk I. A non-invasive measurement of tongue surface temperature. Food Res Int. 2019 Feb;116:499-507. doi: 10.1016/j.foodres.2018.08.066. Epub 2018 Aug 25.
- Mo X, Zhang J, Fan Y, Svensson P, Wang K. Thermal and mechanical quantitative sensory testing in Chinese patients with burning mouth syndrome--a probable neuropathic pain condition? J Headache Pain. 2015;16:84. doi: 10.1186/s10194-015-0565-x. Epub 2015 Sep 24.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3608/2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burning Mouth Syndrome
-
University Hospital, ToursCompletedPrimary Burning Mouth SyndromeFrance
-
University of FloridaCompletedBurning Mouth Syndrome | Burning MouthUnited States
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanUnknownBurning Mouth SyndromeTaiwan
-
Universidad Nacional Autonoma de MexicoUnknownBurning Mouth SyndromeMexico
-
Federico II UniversityRecruitingBurning Mouth SyndromeItaly
-
University of CataniaCompleted
-
Presidio Ospedaliero Garibaldi-CentroUniversity of Padova; University of Catania; Carlo Besta Neurological InstituteCompletedBurning Mouth Syndrome
-
University of ZagrebCompletedMelatonin | Burning Mouth SyndromeCroatia
-
Lu JiangCompletedCaffeine | Burning Mouth SyndromeChina
-
Malmö UniversityLund UniversityNot yet recruitingBurning Mouth Syndrome
Clinical Trials on The objective is to measure the temperature of the lingual dorsum
-
Cambridge University Hospitals NHS Foundation TrustObstetric Anaesthetists' AssociationRecruitingAnesthesiaUnited Kingdom
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Sheba Medical CenterUnknownColonic Polyps | Intestinal Polyps | Colon CarcinomaIsrael
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedSurgery | Stress Urinary IncontinenceTurkey
-
Sohag UniversityCompleted
-
University GhentUniversity Hospital, GhentCompletedHealthy | Traumatic Brain InjuryBelgium
-
Hiroshima UniversityCompleted
-
Turku University HospitalUniversity of TurkuRecruitingMyocardial Infarction | Myocardial IschemiaFinland
-
Yale UniversityNatera, Inc.; Yale Cardiovascular Research GroupSuspendedEndothelial Dysfunction | Microvascular Coronary Artery Disease | Cardiac Allograft VasculopathyUnited States
-
Rennes University HospitalUnknown